BOEHRINGER INGELHEIM PHARMA GMBH&CO. KG,BETAGERI RAJASHEKHAR,BOSANAC TODD,BURKE MICHAEL JASON,HARCKEN CHRISTIAN,KIM SOOJIN,KUZMICH DANIEL,LEE THOMAS WAI-HO,LI ZHIBIN,LIU PINGRONG,LORD JOHN,RAZAVI HOSS
申请号：
SI200930213
公开号：
SI2300472T1
申请日:
2009.06.03
申请国别(地区):
SI
年份:
2012
代理人:
摘要：
Compounds of Formula (I) wherein R1, R2, X, and Y are as defined herein, or a tautomer, optical isomer, prodrug, co-crystal, or salt thereof； pharmaceutical compositions containing such compounds, and methods of modulating the glucocorticoid receptor function and methods of treating disease-states or conditions mediated by the glucocorticoid receptor function or characterized by inflammatory, allergic, or proliferative processes in a patient using these compounds.
